SACRAMENTO, Calif. — The Trump administration is taking its immigration crackdown to the health care safety net, launching Medicaid spending probes in at least six Democratic-led states that provide comprehensive health coverage to poor and disabled immigrants living in the U.S. without permanent legal status. The Centers for Medicare & Medicaid Services is scouring payments…
As public trust in the U.S. healthcare system declines, Intermountain Health CEO Rob Allen thinks that nonprofit hospitals can do a better job showcasing how they reinvest in their communities. He pointed to Intermountain’s work in areas like affordable housing, food access and charity care as examples of nonprofit providers’ often-overlooked value. The post Intermountain…
A promising program can be quickly be derailed by external instability. To prevent this in the future, leaders must ask these essential questions from the start. The post Building Agile Pharmaceutical Programs That Stand Strong Amid Global Health Uncertainty appeared first on MedCity News.
An investigation into cosmetic surgery chains by KFF Health News and NBC News has prompted consumer warnings from industry groups representing plastic surgeons and a call for more transparency around physician disciplinary actions in California. The American Society of Plastic Surgeons, which represents 12,000 doctors, is now warning patients to “do their homework” before getting…
At the HLTH conference in Las Vegas, Colton Underwood and fertility experts highlighted the need to break the stigma around male infertility, urging greater awareness, testing and support to recognize it as a men’s health issue as much as a women’s one. The post How the Stigma Around Male Infertility Can Be Reduced appeared first…
A new analysis shows that individuals with employer insurance could save 41% on their out-of-pocket spending for asthma and COPD inhalers through manufacturer savings. In response to a U.S. Senate investigation into inhaler costs, 3 drug makers voluntarily capped out-of-pocket costs on their brand-name asthma and COPD inhalers.
Novartis is paying $120 million up front to secure rights to a Monte Rosa molecular glue degrader drug candidate as well as options for two others. The two companies began working together last year under an alliance focused on immune mediated-diseases. The post Novartis Adds to Its Immunology Prospects With Another Deal for Monte Rosa’s…
It’s critical that healthcare organizations delivering on the program’s promise not be torpedoed by the “bad actors” The post The Case for 340B Done Right appeared first on MedCity News.
This policy watch examines state-by-state school vaccine requirements and exemptions, including recent policy changes to them and the extent to which they may affect vaccination rates.
Tamir Gottfried, the Chief Commercial and Strategy Officer at TytoCare came on THCB to show us how their remote device works to deliver the last few inches of telehealth. Most telehealth is just a video call but with Tyto’s device, the patient can asynchronously (and/or synchronously) take their vital signs including videos and pictures of…